Vaxcyte, Inc. (PCVX) Misses Q2 EPS by 5c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q2 EPS of ($1.22), $0.05 worse than the analyst estimate of ($1.17).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Medtronic, Inc. (MDT) PT Raised to $115 at Mizuho
• Thoma Bravo's Proofpoint Is Said In Talks To Acquire Varonis - Bloomberg